
Behind Trump's long campaign to target Chinese student visas
President Donald Trump's aides and allies have been laying the groundwork for his aggressive crackdown on Chinese student visas for years.
Trump vowed on the campaign trail in 2023 to ban 'Christian-hating communists, Marxists and socialists' from the country, expanding on efforts from his first administration to shut down China-funded Confucius Institutes on U.S. college campuses and prosecute Chinese scientific researchers and professors at American universities. MAGA allies on the Hill have introduced legislation to this effect in recent years. And during his first term, Trump officials even discussed the early iterations of the very policy Secretary of State Marco Rubio unveiled late Wednesday.
The plan to revoke the student visas is another example of a White House able to build on the policy foundation laid during Trump's first term — turbocharged by planning that took place in the president's four years away from Washington.
While work on student visas had been underway, the president and his aides considered that the timing of the clampdown may complicate a fragile trade truce with China. But the administration forged ahead anyway, said a White House official, granted anonymity to speak candidly about policy discussions.
'The president laid it out there in the campaign… when he says he's going to do something in the campaign, he actually tries to do it,' said Ken Cuccinelli, who served as Trump's deputy of Homeland Security during the first term.
'The reason people like me raised it in the first term is the reason you're hearing from Rubio — there are very real security reasons to not help the Chinese advance their position in technical fields, and certainly not anyone more closely associated with [the Chinese Communist Party].'
The policy released this week circulated among administration officials for months after Trump signed a day one executive order directing the secretary of State to review vetting and screening for immigrants coming to the U.S., including for visa holders. The administration is stacked with aides who have long been laser focused on cracking down on China's influence in U.S. institutions, including senior policy adviser Stephen Miller and Rubio. Both played key roles in finalizing this week's policy announcement across the White House and departments of Homeland Security and State, according to the White House official.
'It was only a matter of time,' the official said. 'It's something that's been so widely discussed for so long.'
Approximately 277,000 Chinese students studied in the U.S. last year, and it remains unclear how many will lose their ability to remain in the country. Rubio vowed to 'aggressively revoke' the visas and said the focus would be on people with connections to the Chinese Communist Party or those studying sensitive subjects.
'The Secretary made this decision in the administration's ongoing effort to protect our homeland from espionage and other hostile actions,' White House press secretary Karoline Leavitt said in a statement.
The administration's action has further fueled tensions between China and the U.S., with Beijing condemning the policy as 'unreasonable' and one that 'damaged the legitimate rights and interests of Chinese students and disrupted the normal cultural exchanges between the two countries.' Last month, Trump placed a 145 percent tariff on Chinese goods but those were reduced to 30 percent when U.S. and Chinese officials reached a temporary agreement. China also reduced its tariffs on American goods to 10 percent from 125 percent.
The trade detente was already in jeopardy as the countries continue to engage in a growing supply chain standoff, with the U.S. this week curbing sales to China of critical U.S. technologies, including software used to make semiconductors. The latest move could further threaten the strained relationship.
The administration's student visa crackdown follows House passage of legislation to deny DHS funding to U.S. colleges and universities with Confucius Institutes or ties to Beijing's security apparatus. And Trump more broadly has targeted international students across the nation's higher education system, pausing interviews for new student visa applicants this week as it weighs expanding social media screening throughout the vetting process.
'They may be using a machete instead of a scalpel at this point,' said Jessica Vaughan, director of policy studies at the Center for Immigration Studies, a group that looks to restrict immigration. 'This is just an agenda item that's been pretty high on the list because of the security importance of it.'
The president's aides and allies view the visa revocations as the initial step in clamping down on Chinese influence in the U.S., with the White House official suggesting it could lead to a wider exclusion of international students from the country. Some allies are hopeful that the administration will next target funding for universities working with Chinese grad students, similar to what the House bill did.
'We have to take things one step at a time,' the White House official said. 'When you're trying to do something big, it's best to start small.'
Trump previewed this week's policy move almost two years ago at the Faith and Freedom Coalition conference in Washington, vowing to use Section 212(f) of the Immigration and Nationality Act to 'deny entry to all communists and Marxists.' U.S. immigration law already bars members of the Communist Party from becoming naturalized citizens or green card holders, but these rules don't apply to people in the U.S. on student or tourist visas.
'Those who come to enjoy our country must love our country,' Trump said. 'We're going to keep foreign, Christian-hating communists, Marxists and socialists out of America.'
But Trump allies have been planting the seeds for much longer. Sen. Tom Cotton (R-Ark.) in 2020 introduced legislation that sought to limit Chinese nationals from obtaining visas for STEM-related studies. The issue has continued to circulate in GOP circles.
Cotton applauded the administration's decision in a statement, saying 'China's use of students to spy on political dissidents and American researchers is a well-documented national security threat.'
Rubio, who introduced another bill alongside Cotton targeting visas for Chinese nationals in 2021, has long invested in the issue. While representing Florida in the U.S. Senate, he pressured local colleges to shut down their Confucius Institutes. He was vocal in his opposition to China, contending in 2022 it 'is the most formidable near-peer adversary our nation has ever faced.'
Andrew Atterbury contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
People Truly Can't Believe The Location This Republican Senator Chose To Film Her "Apology"
I'm sure you've heard of Iowa Senator Joni Ernst's "we all are going to die" thing. She held a townhall on Thursday, and a clip of her comments about SNAP and Medicaid cuts went viral: At her town hall, when the crowd says people will die due to Medicaid and SNAP cuts, Joni Ernst responds "well we all are going to die." #iasen — danny (@dabbs346) May 30, 2025 ABC/dabbs346/Twitter: @dabbs346 Someone from the crowd shouted, "People are going to die," and Joni responded, "Well, we all are going to die." FWIW, The Hill reported she went on to say that Republicans would protect Medicaid for "the most vulnerable." She also said, "SNAP overpayments that the states have been making will need to stop," and "When you are arguing about illegals that are receiving Medicaid benefits, 1.4 million, they're not eligible, so they will be coming off." ANYWAY, this whole thing kind of blew up. People are calling this "one of the worst politician quotes" they've ever heard. And people are joking: "New GOP slogan: 'We're all gonna die!'" Related: 18 Major Global Events That American Media Is Ignoring Right Now, And Why They Actually Matter To Us Sooo, we're on round two from that. Senator Ernst decided to issue an "apology" that isn't really an apology at all. Against all odds, Joni Ernst has made it worse — Keith Edwards (@keithedwards) May 31, 2025 joniernst/Twitter: @keithedwards "Hello everyone, I would like to take this opportunity to sincerely apologize for a statement that I made yesterday at my town hall," she said. "See, I was in the process of answering a question that was asked by an audience member when a woman who was extremely distraught screamed out from the back of the auditorium, 'People are going to die.' And I made an incorrect assumption that everyone in the auditorium understood that, yes, we are all going to perish from this earth." "So, I apologize, and I'm really, really glad that I did not have to bring up the subject of the tooth fairy as well. But for those that would like to see eternal and everlasting life, I encourage you to embrace my Lord and savior Jesus Christ." Related: "I Am So Torn With What You Are Doing" — 11 Posts From MAGA Business Owners Who Are So Close To Getting It Yeaaah, people are unpacking this one. "I'm at a loss for words..." one person said. Another person encouraged her to keep digging in, "Keep posting through it Joni you're almost there." And this person joked, "Leave the tooth fairy out of this, you monster." But the #1 thing people can't believe is the location where she recorded it. It appears that she's walking through a cemetery. "I'm sorry... is she walking through a cemetery as she makes this?" one person asked. Another person said, "No way that Joni Ernst apology video can be real is she in a cemetery." And this person gave her a new nickname: "Senator Grim Reaper." Thoughts? Also in In the News: People Can't Believe This "Disgusting" Donald Trump Jr. Post About Joe Biden's Cancer Diagnosis Is Real Also in In the News: Miss USA's 2024 "National Costume" Has Been Revealed, And It's Obviously An Interesting Choice Also in In the News: One Body Language Expert Spotted Something Very Telling When Donald Trump "Held His Own Hand" At His Recent Press Conference
Yahoo
30 minutes ago
- Yahoo
VNET Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Revenue: CN¥2.25b (up 18% from 1Q 2024). Net loss: CN¥237.6m (loss widened by 27% from 1Q 2024). CN¥0.89 loss per share (further deteriorated from CN¥0.71 loss in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue exceeded analyst estimates by 1.1%. Earnings per share (EPS) missed analyst estimates. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 11% growth forecast for the IT industry in the US. Performance of the American IT industry. The company's shares are down 11% from a week ago. We should say that we've discovered 3 warning signs for VNET Group (2 can't be ignored!) that you should be aware of before investing here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
34 minutes ago
- Yahoo
Do Merit Medical Systems' (NASDAQ:MMSI) Earnings Warrant Your Attention?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. Loss making companies can act like a sponge for capital - so investors should be cautious that they're not throwing good money after bad. Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Merit Medical Systems (NASDAQ:MMSI). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. So it makes sense that experienced investors pay close attention to company EPS when undertaking investment research. It certainly is nice to see that Merit Medical Systems has managed to grow EPS by 34% per year over three years. As a general rule, we'd say that if a company can keep up that sort of growth, shareholders will be beaming. Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. Merit Medical Systems maintained stable EBIT margins over the last year, all while growing revenue 8.2% to US$1.4b. That's a real positive. In the chart below, you can see how the company has grown earnings and revenue, over time. Click on the chart to see the exact numbers. View our latest analysis for Merit Medical Systems The trick, as an investor, is to find companies that are going to perform well in the future, not just in the past. While crystal balls don't exist, you can check our visualization of consensus analyst forecasts for Merit Medical Systems' future EPS 100% free. We would not expect to see insiders owning a large percentage of a US$5.6b company like Merit Medical Systems. But we do take comfort from the fact that they are investors in the company. Notably, they have an enviable stake in the company, worth US$132m. Holders should find this level of insider commitment quite encouraging, since it would ensure that the leaders of the company would also experience their success, or failure, with the stock. If you believe that share price follows earnings per share you should definitely be delving further into Merit Medical Systems' strong EPS growth. With EPS growth rates like that, it's hardly surprising to see company higher-ups place confidence in the company through continuing to hold a significant investment. On the balance of its merits, solid EPS growth and company insiders who are aligned with the shareholders would indicate a business that is worthy of further research. However, before you get too excited we've discovered 1 warning sign for Merit Medical Systems that you should be aware of. There's always the possibility of doing well buying stocks that are not growing earnings and do not have insiders buying shares. But for those who consider these important metrics, we encourage you to check out companies that do have those features. You can access a tailored list of companies which have demonstrated growth backed by significant insider holdings. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data